MARC details
| 000 -LEADER |
|---|
| fixed length control field |
01650cas a22003375i 4500 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
EG-CaNGU |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20240228112400.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
220809t2020 enka fr 001 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9780857113726 |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
EQO |
| Language of cataloging |
eng |
| Transcribing agency |
EQO |
| Modifying agency |
NLM |
| -- |
NLGGC |
| -- |
CUI |
| -- |
DLC |
| -- |
UKMGB |
| -- |
OCLCO |
| -- |
OCL |
| -- |
EUW |
| -- |
OCLCQ |
| -- |
DLC |
| -- |
AU@ |
| -- |
OCLCA |
| -- |
OCL |
| -- |
EG-CaNGU |
| Description conventions |
rda |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
615.1108309 |
| Item number |
BNF |
| Edition number |
23 |
| 130 0# - MAIN ENTRY--UNIFORM TITLE |
|---|
| Uniform title |
British National Formulary, |
| Date of a work |
September 2020-21. |
| 9 (RLIN) |
1081 |
| 245 10 - TITLE STATEMENT |
|---|
| Title |
BNF. |
| Name of part/section of a work |
September 2020 - 21 : |
| Remainder of title |
for children 2020 - 2021 / |
| 246 33 - VARYING FORM OF TITLE |
|---|
| Title proper/short title |
British National Formulary, |
| Number of part/section of a work |
September 2020 - 21 : |
| Remainder of title |
for children 2020 - 2021 |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
|---|
| Place of production, publication, distribution, manufacture |
London, England : |
| Name of producer, publisher, distributor, manufacturer |
BMJ Group, |
| -- |
Pharmaceutical Press, |
| -- |
RCPCH Publications Ltd., |
| Date of production, publication, distribution, manufacture, or copyright notice |
[2020] |
| 264 #4 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
|---|
| Date of production, publication, distribution, manufacture, or copyright notice |
©2020 |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
xviii, 1180 pages : |
| Other physical details |
illustrations ; |
| Dimensions |
21 cm |
| 336 ## - CONTENT TYPE |
|---|
| Content type term |
text |
| Content type code |
txt |
| Source |
rdacontent |
| 337 ## - MEDIA TYPE |
|---|
| Media type term |
unmediated |
| Media type code |
n |
| Source |
rdamedia |
| 338 ## - CARRIER TYPE |
|---|
| Carrier type term |
volume |
| Carrier type code |
nc |
| Source |
rdacarrier |
| 500 ## - GENERAL NOTE |
|---|
| General note |
Includes index. |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Pediatric pharmacology. |
| Source of heading or term |
NGU-sh |
| 9 (RLIN) |
4290 |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Pharmacopoeias. |
| Source of heading or term |
NGU-sh |
| 9 (RLIN) |
4239 |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Pharmacopoeias |
| Geographic subdivision |
Great Britain. |
| Source of heading or term |
NGU-sh |
| 9 (RLIN) |
2575 |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Drugs |
| General subdivision |
administration |
| Source of heading or term |
NGU-sh |
| 9 (RLIN) |
4036 |
| 710 2# - ADDED ENTRY--CORPORATE NAME |
|---|
| Corporate name or jurisdiction name as entry element |
British Medical Association, |
| Relator term |
author. |
| 9 (RLIN) |
1086 |
| 710 2# - ADDED ENTRY--CORPORATE NAME |
|---|
| Corporate name or jurisdiction name as entry element |
Royal Pharmaceutical Society of Great Britain, |
| Relator term |
author. |
| 9 (RLIN) |
1088 |
| 710 2# - ADDED ENTRY--CORPORATE NAME |
|---|
| Corporate name or jurisdiction name as entry element |
Royal College of Paediatrics and Child Health, |
| Relator term |
author. |
| 9 (RLIN) |
4291 |
| 710 2# - ADDED ENTRY--CORPORATE NAME |
|---|
| Corporate name or jurisdiction name as entry element |
Neonatal and Paediatric Pharmacists Group, |
| Relator term |
author. |
| 9 (RLIN) |
4292 |